Farmers & Merchants Investments Inc’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755 Hold
11
﹤0.01% 1597
2026
Q1
$825 Hold
11
﹤0.01% 1528
2025
Q4
$859 Hold
11
﹤0.01% 1499
2025
Q3
$934 Hold
11
﹤0.01% 1497
2025
Q2
$860 Hold
11
﹤0.01% 1493
2025
Q1
$796 Hold
11
﹤0.01% 1511
2024
Q4
$976 Hold
11
﹤0.01% 1486
2024
Q3
$931 Hold
11
﹤0.01% 1506
2024
Q2
$1.02K Hold
11
﹤0.01% 1451
2024
Q1
$1.24K Hold
11
﹤0.01% 1352
2023
Q4
$1.02K Hold
11
﹤0.01% 1434
2023
Q3
$1.01K Buy
11
+2
+22% +$215 ﹤0.01% 1372
2023
Q2
$1.09K Hold
9
﹤0.01% 1358
2023
Q1
$881 Hold
9
﹤0.01% 1429
2022
Q4
$729 Hold
9
﹤0.01% 1501
2022
Q3
$1K Buy
+9
New +$865 ﹤0.01% 1473
2021
Q3
Sell
-10
Closed -$1K 1082
2021
Q2
$1K Buy
+10
New +$1.15K ﹤0.01% 932

Other funds holding USPH

Farmers & Merchants Investments Inc's USPH Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its US Physical Therapy (USPH) position steady in Q2 2026 at 11 shares worth $755. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Farmers & Merchants Investments Inc first reported a position in USPH in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.24K in Q1 2024. 91 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Farmers & Merchants Investments Inc held 11 shares of US Physical Therapy worth $755 as of Q2 2026.
  • Farmers & Merchants Investments Inc left its US Physical Therapy share count unchanged in Q2 2026.
  • US Physical Therapy made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1597 holding.
  • Farmers & Merchants Investments Inc first reported a position in US Physical Therapy in Q2 2021 and has held it in 17 quarters since.
  • Farmers & Merchants Investments Inc's US Physical Therapy position peaked at $1.24K in Q1 2024.
  • 91 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.